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Clinically-evident tophi are associated with
reduced muscle force in the foot and ankle
in people with gout: a cross-sectional study
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Abstract
Background: The foot and ankle represent a common site for tophi in people with gout, yet it is unclear whether
the presence of tophi is related to impaired muscle function. This study aimed to determine the association between
foot and ankle tophi and muscle force in people with gout.
Methods: Participants with gout were stratified into two groups based on the presence of clinically-evident tophi
affecting the foot or ankle on physical examination. Isometric muscle force for plantarflexion, dorsiflexion, inversion and
eversion was measured using static dynamometry. Mixed-models regression was used to determine the difference in
muscle force between the two groups while adjusting for age, disease duration and foot pain. This model was also
used to determine the difference in muscle force between presence and absence of tophi at specific locations within
the foot and ankle. In addition, Pearson’s correlations were used to determine the association between total foot
tophus count and muscle force.
Results: Fifty-seven participants were included (22 with foot or ankle tophi and 35 without foot or ankle tophi). Foot
and ankle tophi were most often seen at the Achilles tendon. After adjusting for age, disease duration and foot pain,
participants with tophi had significantly reduced muscle force during plantarflexion (P < 0.001), dorsiflexion (P = 0.003),
inversion (P = 0.003) and eversion (P = 0.001) when compared to participants without tophi. Those with Achilles tophi
had significantly reduced force during plantarflexion (P < 0.001), inversion (P = 0.008) and eversion (P = 0.001). No
significant differences in muscle force were observed between the presence and absence of tophi at other foot or ankle
locations. There were also no significant correlations between total foot tophus count and muscle force (all P > 0.05).
Conclusion: In people with gout, clinically-evident foot or ankle tophi are associated with muscle force deficits during
foot plantarflexion, dorsiflexion, inversion and eversion, which persist despite adjusting for age, disease duration and
foot pain. Tophi at the Achilles tendon, which associate with force deficits, may contribute to reduced muscular activation
and consequent disuse muscle atrophy.
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Background
Gout is a common form of arthritis resulting from the
deposition of monosodium urate (MSU) crystals in struc-
tures of the musculoskeletal system [1–3]. In the absence
of urate-lowering therapy, tophi develop in some people
with long-standing gout [4, 5], and result from accu-
mulation of MSU crystals and a chronic inflammatory
granulomatous tissue response [6]. Tophi form within
subcutaneous tissues, joints and tendons and contribute
to clinical features of chronic arthropathy, including in-
flammation, pain and joint effusion [7, 8]. Intra-articular
tophi have been associated with limitations in function
and mechanics of joints in both the upper limb [9] and
knees in people with gout [10]. The functional impact of
tophi has also been reported to limit the ability of people
with gout to participate in normal daily activities [11].
The foot and ankle regions represent a major site for to-
phus deposition [12–15] and people with gout experience
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persistent pain and disability related to the foot [16, 17].
Lower limb, foot and ankle biomechanical studies have
shown walking impairments [18–20] and a loss of normal
foot joint function in people with gout [21]. Furthermore,
foot and ankle muscle force in people with gout is signifi-
cantly reduced compared to people without gout [22].
Foot and ankle muscle strength plays a fundamental role
in the ability to carry out functional activities, including
walking. Despite the prominent foot-related disability and
impairment observed in people with tophaceous gout, the
relationship between tophus presence and muscle force in
the foot has not been yet been assessed.
Despite the frequent prevalence of tophus deposition
within the foot and ankle [12–14], it is unclear whether
tophus presence is associated with local impairments in
foot and ankle muscle strength in people with gout. The
aim of this study was to determine the association be-
tween clinically-evident tophi and muscle force in the
foot and ankle in people with gout.
Methods
Participants with gout were recruited from the rheuma-
tology department at Counties Manukau District Health
Board, Auckland, New Zealand. All participants fulfilled
the 1977 preliminary American Rheumatism Association
gout classification criteria [23]. Participants were ex-
cluded if they were <20 years old, had undergone foot
and/or ankle surgery in the previous 3 months, had a
history of other inflammatory arthritis, were unable to
walk 10 m unaided, or were experiencing an episode of
acute arthritis at the time of the clinical visit. The study
was approved by the Auckland University Ethics Com-
mittee (14/57). All participants provided written in-
formed consent prior to data collection.
Participants were stratified into two groups based on
the presence or absence of at least one clinically-evident
tophi in either the right or left foot or ankle region. As-
sessment for tophi was undertaken by a single podiatric
researcher with experience in the clinical assessment of
gout (SO). Tophi were defined as palpable nodules evident
within periarticular or subcutaneous tissue, which is a
simple and feasible method for tophus assessment [24].
The location of tophi in each foot was also recorded.
Demographic information including age, sex, ethnicity,
body mass index (BMI), current medications and co-
morbidities was recorded for all participants. Gout dis-
ease characteristics, including disease duration and flare
history were also recorded. Patient-reported foot pain
and global pain over the past week were assessed using
100 mm Visual Analog Scales (VAS) [25]. Foot-related
pain and disability was measured using the Manchester
Foot Pain and Disability Index [26].
Isometric muscle force for ankle plantarflexion, dorsi-
flexion, inversion and eversion was measured using a
CITEC hand-held dynamometer (CIT Technics, Haren,
Netherlands). Hand-held dynamometry provides an
easy-to-use tool for the objective quantification of
muscle strength in clinical settings and has been shown
to be reliable for assessment of foot and ankle muscles
[27]. The device is calibrated to a sensitivity of 0.1% and
a range of 0 to 500 N (N). Participants were positioned
seated during testing with hips flexed and knees ex-
tended. The examiner stabilised the lower leg and foot
proximal to the ankle joint with the foot and ankle
maintained in a neutral position. Three consecutive con-
tractions of three to 5 seconds were performed for each
muscle group and the maximum force for each contrac-
tion was recorded. The ‘make’ technique, in which the
examiner held the dynamometer stationary while the
participant exerted maximal external force against it
[27]. The dynamometer was positioned on the plantar
aspect of the foot proximal to the metatarsophalangeal
joints for plantarflexion; on the dorsum of the foot prox-
imal to the metatarsophalangeal joints for dorsiflexion;
on the medial aspect of the first metatarsal shaft for in-
version; and on the lateral aspect of the fifth metatarsal
shaft for eversion. The mean of the three measurements
for each right and left limbs were used in the analysis.
Data were analysed using SPSS version 20.0 (IBM Corp.,
Armonk, NY). Measures between participants with foot
and/or ankle tophi and those without foot and/or ankle
tophi were compared using mixed linear regression
models. A participant-specific and participant-nested ran-
dom effect for foot-side was included in the model to ac-
count for the repeated measures in the right and left feet
for each individual participant. All analyses were adjusted
for age, disease duration and foot pain VAS. To account
for multiplicity, a Bonferroni adjusted alpha of P < 0.0125
was used when analysing the four muscle groups. The
same mixed linear regression model was also used to de-
termine the difference in muscle force between partici-
pants with and without foot or ankle tophus at each of the
following seven sites: hallux, lesser toes, first metatarso-
phalangeal joint (1MTP), lesser metatarsophalangeal joints
(MTPs), midfoot, heel and Achilles tendon. In addition,
the correlation between total number of clinically-evident
tophi at the foot and/or ankle and the muscle force out-
comes were assessed using Pearson’s correlation testing.
Results
A total of 57 participants were included in the study
(Table 1). Thirty-five participants had no clinical evi-
dence of tophi in the foot or ankles, and 22 had clinical
evidence of foot and ankle tophi. In those with foot or
ankle tophi present, the mean (SD) foot tophus count
was 4.6 (5.6). The most common area for tophi in this
group was the Achilles tendon (n = 16 tendons, 36%)
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(Fig. 1). Of those participants with Achilles tendon tophi,
all had tophi present in at least one other location in the
body. Participants in both groups were primarily middle-
aged men with frequent comorbidities, including hyper-
tension, cardiovascular disease and diabetes. Participants
with foot tophi had a significantly longer gout disease
duration compared to the group with no foot tophi
present (P < 0.001) and had a significantly higher overall
body tophus count (P = 0.001). Participants with foot
tophi also reported significantly greater foot pain and
disability scores (MFPDI) compared to those with no
foot tophi (P = 0.044).
Table 1 Participant characteristics
Foot or ankle tophi P
Absent Present
N 35 22
Male, n (%) 31 (89%) 19 (86%) 0.81
Age, years 60 (14) 60 (12) 0.89
BMI, kg/m2 33 (8) 33 (6) 0.68
Ethnicity
European, n (%) 11 (31%) 6 (27%) 0.26
Māori, n (%) 8 (23%) 3 (14%)
Pacific, n (%) 13 (37%) 13 (59%)
Asian, n (%) 3 (9%) 0 (0%)
Type 2 diabetes, n (%) 14 (40%) 7 (32%) 0.53
Stage 3 or worse chronic kidney disease, n (%)a 19 (54%) 17 (77%) 0.06
Hypertension, n (%) 26 (74%) 16 (73%) 0.90
Cardiovascular disease, n (%) 12 (34%) 6 (27%) 0.58
Gout disease duration, years 11 (10) 25 (13) < 0.001
Gout flares in previous 3 months 0.6 (1.1) 0.5 (0.9) 0.55
Serum urate, mmol/L 0.41 (0.13) 0.39 (0.13) 0.58
Urate lowering therapy, n (%) 31 (89%) 21 (96%) 0.59
Total foot tophus count 0 (0) 4.6 (5.6) 0.001
Total body tophus count 1.7 (4.6) 12.9 (12.8) 0.001
Foot pain VAS, mm 5.7 (30.4) 15.5 (38.5) 0.05
Global pain VAS, mm 12.4 (27.9) 14.4 (35.5) 0.74
Manchester Foot Pain and Disability Index 10.6 (12.5) 16.6 (15.8) 0.044
Values are mean (SD) unless otherwise specified. aDefined as estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73mm2; bFor those in employment;
Bolded P values indicate significant difference between groups at P < 0.05. BMI body mass index, VAS visual analogue scale
Fig. 1 Location of tophi in participants with foot or ankle tophi (n = 44 ft). MTP: metatarsophalangeal joint
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The distribution of residuals from the linear models
for all muscle force variables demonstrated sufficient
normality to carry out parametric testing. After adjusting
for age, disease duration and pain score, participants
with foot or ankle tophi had significantly reduced muscle
force compared to participants without tophi during
plantarflexion (75.4 N vs. 99.9 N, P < 0.001), dorsiflexion
(55.7 N vs. 74.2 N, P = 0.003), inversion (45.5 N vs.
58.2 N, P = 0.003) and eversion (43.4 N vs. 56.2 N,
P = 0.001) when compared to participants with no foot
tophi (Table 2). The site specific analysis revealed that
participants with tophi at the Achilles tendon demon-
strated reduced muscle force compared to participants
without Achilles tendon tophi during plantarflexion
(94.2 N vs, 65.1 N, P < 0.001), inversion (54.9 N vs.
40.9 N, P = 0.008) and eversion (53.4 N vs. 37.0 N,
P = 0.001). A similar non-significant trend was also
noted with Achilles tendon tophi and dorsiflexion force
(69.4 N vs. 51.2 N, P = 0.016) (Table 3). No differences
were noted in muscle force between the presence and
absence of tophi at the other foot sites (P > 0.05). There
were no correlations between muscle force and number
of tophi affecting the foot and ankle (−0.11 > r < 0.02,
P > 0.26 for all analyses).
Discussion
This study has shown that in the presence of clinically-
evident tophi within the foot and ankle, muscle force is
significantly reduced in plantarflexion, dorsiflexion, in-
version and eversion, when compared to people with
gout who do not have clinical evidence of foot or ankle
tophi. The analysis also suggests that tophi at the Achilles
tendon may play a role in force reductions not only
during plantarflexion, but also during inversion and
eversion of the foot.
While it is possible that intra-muscular tophus depos-
ition would reduce the working area of the muscle and
its ability to produce adequate force [28], it seems un-
likely that this is a dominant mechanism. Numerous
studies have reported tophus deposition within joints,
tendons and ligaments involved in foot and ankle func-
tion [12, 14, 29], but muscle deposition appears to be
rare, with evidence limited to a few case reports [30].
The presence of intra-articular tophus has been shown
to limit joint motion in the knee [10] and it is possible
that restrictions to normal joint motion may also com-
promise the potential for muscles to generate force.
It has been hypothesised that the pain-avoidance gait
strategies employed by people with gout may contribute
to reduced muscle activity and consequent disuse
muscle atrophy [18–20]. Although the current results
demonstrated an association between reduced muscle
force and pain, even after adjusting for pain scores, it
should be noted that pain was assessed over the past
week and may not capture cumulative pain over the
course of the disease. Several studies assessing foot pain
over a longer duration (3 to 20 months) in people with
musculoskeletal pathology, have reported associations
between foot muscle strength and foot pain [31–33].
The Achilles tendon was the most common site for to-
phus presence in the foot and ankle of participants,
which is consistent with published work using dual-
energy computed tomography [29]. The Achilles tendon
plays a major role in sagittal plane motion during the
gait cycle and works alongside muscular contractions
during plantarflexion to assist in the propulsion of body
weight [34]. Although construct validity of dynamometry
relative to dynamic muscle forces during gait in this
population has not been determined, the findings from
the current study may suggest that any tophus-
associated restrictions in normal function may contrib-
ute to the reduced muscular activation during plantar-
flexion and consequent disuse muscle atrophy.
It is unclear whether the addition of muscle weakness
in those with subcutaneous tophi further impairs their
ability to carry out functional activities of daily living, in-
cluding walking [19, 20]. Weakness of foot and ankle
musculature has been associated with poor balance and
an increased risk of falls in the elderly [35], as well as
foot deformity, including hallux valgus - which is com-
mon in people with gout [17, 21]. The clinical impact of
foot muscle weakness in people with tophaceous gout
will be the subject of further research.
The findings from this study should be considered in
light of several limitations. The cross-sectional nature of
the study limits the ability to determine causation with
Table 2 Association between foot and ankle tophus presence and muscle forcea
Least-squares mean (SD) Diff. 95% CI for Diff. P
Foot/ankle tophus absent Foot/ankle tophus present Lower Upper
Plantarflexion force, N 99.9 (31.5) 75.4 (31.0) 24.5 11.5 37.4 <0.001
Dorsiflexion force, N 74.2 (28.9) 55.7 (18.3) 18.5 6.6 30.3 0.003
Inversion force, N 58.2 (20.2) 45.5 (19.6) 12.6 4.4 20.9 0.003
Eversion force, N 56.2 (19.3) 43.4 (18.8) 12.9 5.0 20.8 0.001
aResults are presented adjusted for gout disease duration, age and foot pain VAS. Bolded P values indicate significant difference between groups at Bonferroni-
adjusted significance level of P < 0.0125. Diff. difference in least-squares mean between the two groups, CI confidence interval
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regard to whether tophus deposition within the mus-
culoskeletal system impairs muscular function and
strength, or whether pre-existing abnormalities in mus-
culoskeletal foot function and mechanics predisposes to
local urate crystal deposition. The foot pain VAS used in
the current study assessed average pain over the past
week and may not reflect pain levels experienced earlier
in the disease, which may also impact the muscle force
assessed during the study. Additionally, physical activity
and its relationship with pain, which was not assessed in
the current study, may have contributed to the muscle
strength deficits. Tophus presence was assessed by
clinical examination, which may not be reflective of the
true tophus burden in people with gout, evident by im-
aging studies that have demonstrated subclinical urate
deposition in the foot [36]. Static dynamometry may not
be reflective of muscle activity during gait. Furthermore,
although static dynamometry was chosen based on its
clinical utility, it also has limited validity in testing stron-
ger muscle groups such as the plantarflexors due to the
possibility of overpowering the examiner [37]. Finally,
the examiner could not be blinded to the presence or
absence of foot/ankle tophi during muscle testing, and
therefore was not blinded to the participant’s group allo-
cation. Although dynamometry is primarily participant-
dependent, the possibility of bias related to lack of asses-
sor blinding cannot be excluded.
Longitudinal studies are required to determine the role
of tophi in the mechanism for muscle weakness in gout.
Additionally, the association between strength deficits
Table 3 Association between tophus location at each site in the foot and ankle and muscle forcea
Least-squares mean (SD) Diff. 95% CI P
Tophus location Absent Present Lower Upper
Plantarflexion force Hallux 91.3 (30.2) 72.1 (29.4) 19.1 −2.6 40.9 0.083
Lesser Toes 92.2 (30.1) 77.5 (29.4) 14.7 −0.9 30.3 0.065
First MTP 91.0 (30.4) 77.7 (29.8) 13.4 −6.1 32.8 0.175
Lesser MTPs 89.6 (30.5) 100.0 (29.3) −10.3 −52.3 31.6 0.627
Midfoot 89.4 (30.4) 101.6 (29.8) −12.3 −42.4 17.9 0.422
Heel 89.3 (30.3) 117.5 (28.6) −28.2 −69.6 13.2 0.177
Achilles 94.2 (29.1) 65.1 (29.3) 29.1 13.2 45.0 <0.001
Dorsiflexion force Hallux 68.1 (26.8) 47.9 (25.8) 20.2 1.1 39.3 0.038
Lesser Toes 67.9 (27.3) 59.5 (26.8) 8.4 −5.8 22.6 0.243
First MTP 66.5 (27.5) 67.3 (27.0) −0.7 −18.4 16.9 0.933
Lesser MTPs 66.9 (27.4) 52.3 (26.3) 14.6 −23.1 52.3 0.444
Midfoot 66.0 (27.3) 81.4 (26.8) −15.4 −42.6 11.7 0.262
Heel 66.1 (27.2) 94.8 (27.2) −28.7 −68.0 10.6 0.149
Achilles 69.4 (27.1) 51.2 (27.1) 18.2 3.4 32.9 0.016
Inversion force Hallux 53.4 (19.1) 46.4 (18.8) 7.1 −6.8 21.0 0.314
Lesser Toes 53.7 (19.1) 48.7 (18.4) 5.0 −4.8 14.9 0.311
First MTP 53.0 (19.2) 52.2 (18.8) 0.8 −11.5 13.1 0.899
Lesser MTPs 53.0 (19.1) 48.6 (18.3) 4.4 −21.9 30.6 0.742
Midfoot 52.3 (18.9) 66.4 (18.4) −14.1 −32.7 4.6 0.137
Heel 52.4 (18.8) 72.4 (16.8) −20.0 −44.4 4.4 0.106
Achilles 54.9 (18.6) 40.9 (18.8) 14.0 3.8 24.2 0.008
Eversion force Hallux 51.5 (18.2) 43.7 (17.4) 7.8 −5.1 20.8 0.233
Lesser Toes 50.9 (18.3) 50.9 (18.0) 0.0 −9.5 9.6 0.997
First MTP 50.9 (18.3) 50.6 (18.0) 0.3 −11.4 12.0 0.962
Lesser MTPs 50.9 (18.3) 48.9 (17.6) 2.0 −23.2 27.2 0.875
Midfoot 50.6 (18.2) 58.7 (17.9) −8.2 −26.3 10.0 0.374
Heel 50.7 (18.2) 63.2 (18.6) −12.5 −39.5 14.4 0.355
Achilles 53.4 (17.7) 37.0 (17.6) 16.4 6.8 26.0 0.001
aResults are presented adjusted for gout disease duration, age and foot pain VAS. Bolded P values indicate significant difference between groups at Bonferroni-
adjusted significance level of P < 0.0125. Diff. Difference in least-squares mean between the two groups, CI confidence interval
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and spatiotemporal gait parameters in people with gout
may also be assessed. Future work may also employ ad-
vanced imaging techniques, such musculoskeletal ultra-
sound or dual energy computed tomography, to assess
the impact of subclinical tophus burden on joint and
muscle function in people with gout, both during non-
weight bearing and dynamic gait testing. This would
greatly advance current understanding of specific factors
that may contribute to muscle atrophy as a result of
local crystal deposition, including the adoption of pain-
avoidance gait strategies, mechanical joint restrictions
and impaired musculotendinous function.
Conclusions
In conclusion, this study has shown that people with
gout who have clinically-evident foot or ankle tophi
demonstrate significant muscle force deficits during foot
plantarflexion, dorsiflexion, inversion and eversion when
compared to those without tophi, even after adjusting
for recent foot pain, suggesting that other factors may
also be driving muscle atrophy in people with gout. This
study has also shown that tophus presence specifically at
the Achilles tendon is associated with foot and ankle
muscle force deficits.
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